Arvinas (ARVN) Asset Utilization Ratio (2018 - 2026)

Arvinas' (ARVN) quarterly Asset Utilization Ratio came in at 0.13 in Q1 2026, down 67.91% year-on-year from 0.41 in Q1 2025, and down 61.05% quarter-over-quarter from 0.34 in Q4 2025.

Arvinas (ARVN) Asset Utilization Ratio (2018 - 2026) Analysis & Trends

Arvinas' Asset Utilization Ratio history runs 9 years deep, the most recent figure standing at 0.13 for Q1 2026.

  • On a quarterly basis, Asset Utilization Ratio fell 67.91% year-over-year to 0.13 in Q1 2026; TTM through Mar 2026 was 0.13, a 67.91% decrease from a year earlier, with the FY2025 full-year figure at 0.29, up 32.02% from the prior year.
  • Asset Utilization Ratio retreated to 0.13 in Q1 2026 per ARVN's latest filing, from 0.34 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.41 in Q1 2025 and bottomed at 0.05 in Q1 2022.
  • The 5-year median for Asset Utilization Ratio is 0.13 (2026), against an average of 0.17.
  • Across the five-year window, Asset Utilization Ratio surged 620.26% in 2025 and tumbled 67.91% in 2026, its largest moves.
  • Year by year, Asset Utilization Ratio stood at 0.1 in 2022, then tumbled by 34.12% to 0.07 in 2023, then surged by 251.05% to 0.23 in 2024, then surged by 44.13% to 0.34 in 2025, then slumped by 61.05% to 0.13 in 2026.
  • Per Business Quant, the three latest ARVN Asset Utilization Ratio figures stand at 0.13 (Q1 2026), 0.34 (Q4 2025), and 0.36 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.69
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 0.47
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.37
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Arvinas 519.68 Mn -95.22 Mn - 0.13

Historic Data

Download Data
DateValue
Mar 31, 2026 0.13
Dec 31, 2025 0.34
Sep 30, 2025 0.36
Jun 30, 2025 0.39
Mar 31, 2025 0.41
Dec 31, 2024 0.23
Sep 30, 2024 0.13
Jun 30, 2024 0.07
Mar 31, 2024 0.06
Dec 31, 2023 0.07
Sep 30, 2023 0.15
Jun 30, 2023 0.14
Mar 31, 2023 0.11
Dec 31, 2022 0.10
Sep 30, 2022 0.09
Jun 30, 2022 0.07
Mar 31, 2022 0.05
Dec 31, 2021 0.03
Sep 30, 2021 0.02
Jun 30, 2021 0.04